Inflammatory Arthritis Clinical Trial
Official title:
Addressing Rural and Remote Access Disparities for Patients With Inflammatory Arthritis Through Telehealth/Videoconferencing and Innovative Inter-professional Care Models
This project will be conducted in two phases. Phase 1: RA patients will be recruited to participate in five repeated examinations occurring in one day to compare between and within specialties, ensuring reasonable equivalency of examination findings. Phase 2: RA patients living > 100 km from Saskatoon will be randomized to the intervention or control group, with both groups having three follow-up appointments in 3-month intervals. The intervention group will be evaluated by a physiotherapist supported by a rheumatologist through videoconferencing, while the control group will continue to travel to Saskatoon for follow-up care.
Part A: Validation Study This study involves inter-professional care with rural-based
physical therapists and urban-based rheumatologists, it will be a valuable first step to
validate comparability of the physical examination. We shall compare physical examination
accuracy between and within examiner disciplines. Examiners will include the three
rheumatologist study investigators and three participating physical therapists with
additional training in inflammatory rheumatic diseases and experienced in musculoskeletal
assessment.
Procedures: All examiners will undergo a standardized review of examination techniques and
documentation prior to participating.
Comparison groups will be:
1. Rheumatologist A. to Rheumatologist B.
2. Physiotherapist A. to Physiotherapist B.
3. Rheumatologist A/B to Physiotherapist C/teleconferenced Rheumatologist C. We will use
web-based videoconferencing software. This desktop-based solution is currently being
piloted by Telehealth Saskatchewan and is used extensively in Ontario. This technology
satisfies Health Information Protection Act (HIPA) as well as the Saskatchewan privacy
and security concerns. An examining room with telehealth/videoconference equipment will
be available for patient distance examination for comparison group C as listed above.
The rheumatologist will be in a physically separate room with viewing equipment in a
mock distance evaluation. The proposed study will be conducted in cooperation with the
Canadian Centre for Health and Safety in Agriculture (CCHSA) within the ≈1350 m2
National Agricultural-Industrial Hygiene Laboratory. Clinical visits will be conducted
at the CCHSA.
Part B: Randomized Controlled Rheumatoid Arthritis Care Delivery Model Trial Randomization:
Participating patients will be randomly allocated to two arms, either to be followed by
telehealth/videoconferencing in or near their home community or to continue traveling to
their Saskatoon rheumatology clinic.
Intervention: One study arm will be followed in traditional rheumatology clinic (in-person
examining rheumatologist). The second study arm will be followed by
telehealth/videoconferencing. Patients in the telehealth/videoconferencing arm will be
examined by a rural-based physical therapist who will report exam findings during telehealth
review with the urban-based rheumatologist. Follow-up visits will be every three months in
both arms. All patients will complete standardized history/data-collection forms. Patients
will be followed in their respective study arms for nine months, and then will be evaluated
in-person in rheumatology clinic for final face-to-face disease activity evaluation.
;
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04249817 -
Keeping Stable Inflammatory Arthritis Patients in Their Communities With the Advanced Clinician Practitioner in Arthritis Care
|
N/A | |
Not yet recruiting |
NCT06162195 -
The ACTIVE Trial: A Prospective Randomised Control Trial Of The H1 Implant Versus Total Hip Replacement
|
N/A | |
Completed |
NCT01303874 -
Etanercept and Methotrexate in Patients to Induce Remission in Early Arthritis (EMPIRE)
|
Phase 4 | |
Active, not recruiting |
NCT03343171 -
Continuum Ceramic on Ceramic Bearing Post Market Clinical Follow-Up Study
|
||
Recruiting |
NCT04426747 -
Impact of Barriers and Facilitators to Physical Activity in Patients With Inflammatory Arthritis
|
||
Active, not recruiting |
NCT04956380 -
Self-assessment Triage in Inflammatory Arthritis
|
N/A | |
Active, not recruiting |
NCT02538757 -
Safety and Effectiveness Study of the Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE)
|
Phase 2 | |
Completed |
NCT01874067 -
C-GLOVES: the Effectiveness of Compression Gloves in Arthritis
|
||
Completed |
NCT03140995 -
Sleep and Exercise in Rheumatoid Arthritis
|
N/A | |
Withdrawn |
NCT02027298 -
Abatacept for Patients With Inflammatory Arthritis Associated With Sjögren's Syndrome: an Open-Label Phase II Study
|
Phase 2 | |
Recruiting |
NCT00512239 -
Prognostic Evaluation of Inflammatory Polyarthritis of Recent Onset
|
||
Terminated |
NCT03937856 -
Smartphone Mindfulness Meditation for Patients With Rheumatic Diseases
|
N/A | |
Completed |
NCT02436785 -
Do Inflammatory Arthritis Inpatients Receiving Group Music Therapy Improve Pain Compared to Music Listening?
|
N/A | |
Completed |
NCT02538341 -
Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial)
|
Phase 2 | |
Completed |
NCT02465879 -
Allied Health in Rheumatology Triage Project
|
N/A | |
Completed |
NCT03672916 -
Allofit® IT Ceramic Bearing System in Total Hip Arthroplasty
|
||
Completed |
NCT04806867 -
Selection of Patients With Chronic Inflammatory Rheumatism Requiring Management During the COVID-19 Pandemia
|
||
Active, not recruiting |
NCT01307384 -
Zimmer Continuum Metal on Polyethylene (MoP) PostMarket Clinical Followup (PMCF) Study
|
||
Terminated |
NCT03672370 -
PMCF Study on the Safety and Performance of the Alloclassic Variall Cup Ceramic Bearing System in Total Hip Arthroplasty
|
||
Not yet recruiting |
NCT05216757 -
Efficacy and Safety of Iguratimod in Patients With Hand Osteoarthritis (ESIGO)
|
Phase 2/Phase 3 |